Pacific 8 Ventures

Pacific 8 Ventures is an active venture capital firm founded in ~2015–2016 that invests at the intersection of disruptive technology platforms and healthcare/life sciences. The fund focuses on early-stage startups—often as the first institutional investor—in areas such as synthetic biology, gene editing/CRISPR, digital health, AI/machine learning-enabled diagnostics and therapeutics. Its portfolio spans US and Greater China markets with a strong network among hospital groups and insurers. Notable investments include Mammoth Biosciences, BillionToOne, Fauna Bio, Dorian Therapeutics, Matrisome Bio, Elsa Fertility among others. The fund does not develop drugs directly but backs innovative biotech/healthtech startups across modalities including gene editing/gene therapy, cell therapies/CAR-Ts for cancer/immunology indications as well as digital health solutions.